Australian Trachoma Surveillance Report 2014

Trachoma is one of the major causes of preventable blindness globally. It is an eye infection caused by the bacterium Chlamydia trachomatis (C. trachomatis) serotypes A, B, Ba and C. The infection can be transmitted through close facial contact, hand-to-eye contact, via fomites (towels, clothing and bedding) or by flies. Trachoma is generally found in dry, dusty environments and is linked to poor living conditions. Overcrowding of households, limited water supply for bathing and general hygiene, poor waste disposal systems and high numbers of flies are all associated with trachoma. Children generally have the highest prevalence of trachoma and are believed to be the main reservoirs of infection due to longer durations of infection compared to adults.

Australia is the only developed country where trachoma is still endemic. It occurs primarily in remote and very remote Aboriginal communities in the Northern Territory, South Australia and Western Australia. In 2008, cases were also found in Aboriginal communities in New South Wales and Queensland, regions where trachoma was believed to have been eliminated. In Australia, the surveillance and management of trachoma is guided by the Communicable Disease Network of Australia (CDNA) Guidelines for the Public Health Management of Trachoma in Australia 2006. This document encompasses the WHO SAFE strategies and provides recommendations for improving data collection, collation and reporting systems.

The National Trachoma Surveillance and Reporting Unit (NTSRU) is responsible for trachoma data collation, analysis and reporting related to the ongoing evaluation of trachoma control strategies in Australia. It operates under contract with the Australian Government Department of Health and Ageing, and its primary focus is the three jurisdictions that have been funded to undertake trachoma control activities by the Australian Government.

Key findings
  • Jurisdictions identified 160 communities as being at‑risk or potentially at‑risk of trachoma. The number of communities designated as being at‑risk has decreased marginally in the NT, and substantially decreased in SA and WA since 2012.
  • Screening coverage in children aged 5 – 9 years in at‑risk communities was 92% for the NT, 87% for SA, 91% for WA and 63% for NSW.
  • A total of 4,241 children aged 5 – 9 years in 125 at‑risk communities were assessed for clean faces during 2014.
  • The overall prevalence of active trachoma among children aged 5 – 9 years in screened communities was 4.7%, with 5.9% in the NT, 4% in SA, 2.9% in WA and 0% in NSW.
  • Overall 9,497 adults aged over 15 years were screened. It is acknowledged that the data provided do not include trichiasis screening undertaken as part of the Adult Health Check MBS Item 715. These data are not available to the National Trachoma Surveillance and Reporting Unit.